These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20920814)

  • 21. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A vaccines and the elderly.
    Genton B; D'Acremont V; Furrer HJ; Hatz C; Louis Loutan
    Travel Med Infect Dis; 2006 Dec; 4(6):303-12. PubMed ID: 17098625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
    Barkai G; Belmaker I; Givon-Lavi N; Dagan R
    Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly.
    D'Acremont V; Herzog C; Genton B
    J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey.
    Batra Y; Bhatkal B; Ojha B; Kaur K; Saraya A; Panda SK; Acharya SK
    Bull World Health Organ; 2002; 80(9):728-31. PubMed ID: 12378291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A.
    Rahaman SM; Chira P; Koff RS
    Am J Gastroenterol; 1994 Jan; 89(1):106-8. PubMed ID: 8273775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HAV infection in chronic liver disease: a rationale for vaccination.
    Almasio PL; Amoroso P
    Vaccine; 2003 Jun; 21(19-20):2238-41. PubMed ID: 12744849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune hepatitis--sequel of a relapsing hepatitis A in a 75-year-old woman.
    Grünhage F; Spengler U; Fischer HP; Sauerbruch T
    Digestion; 2004; 70(3):187-91. PubMed ID: 15557764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing incidence of hepatitis A in Korean adults.
    Kim YJ; Lee HS
    Intervirology; 2010; 53(1):10-4. PubMed ID: 20068335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.
    Melgaço JG; Pinto MA; Rocha AM; Freire M; Gaspar LP; Lima SM; Cruz OG; Vitral CL
    J Med Virol; 2011 Feb; 83(2):208-17. PubMed ID: 21181914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
    Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
    J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case report: Hepatitis A preceding Guillain-Barré syndrome.
    Chitambar SD; Fadnis RS; Joshi MS; Habbu A; Bhatia SG
    J Med Virol; 2006 Aug; 78(8):1011-4. PubMed ID: 16789022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs.
    Pancharoen C; Mekmullica J; Thisyakorn U; Kasempimolporn S; Wilde H; Herzog C
    Clin Infect Dis; 2005 Nov; 41(10):1537-40. PubMed ID: 16231271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined vaccine against hepatitis A and B].
    Pawłowska M; Halota W; Kozielewicz D
    Przegl Epidemiol; 2004; 58 Suppl 1():66-70. PubMed ID: 15807160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
    Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
    Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
    Jabłkowski M; Kuydowicz J; Strzelczyk J; Białkowska J
    Med Sci Monit; 2002 Nov; 8(11):CR762-6. PubMed ID: 12444381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial.
    Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M
    J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.